These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

108 related articles for article (PubMed ID: 22070526)

  • 1. In vitro tests for aerosol deposition. I: Scaling a physical model of the upper airways to predict drug deposition variation in normal humans.
    Delvadia RR; Longest PW; Byron PR
    J Aerosol Med Pulm Drug Deliv; 2012 Feb; 25(1):32-40. PubMed ID: 22070526
    [TBL] [Abstract][Full Text] [Related]  

  • 2. In vitro tests for aerosol deposition II: IVIVCs for different dry powder inhalers in normal adults.
    Delvadia R; Hindle M; Longest PW; Byron PR
    J Aerosol Med Pulm Drug Deliv; 2013 Jun; 26(3):138-44. PubMed ID: 22947131
    [TBL] [Abstract][Full Text] [Related]  

  • 3. In Vitro Tests for Aerosol Deposition. IV: Simulating Variations in Human Breath Profiles for Realistic DPI Testing.
    Delvadia RR; Wei X; Longest PW; Venitz J; Byron PR
    J Aerosol Med Pulm Drug Deliv; 2016 Apr; 29(2):196-206. PubMed ID: 26447531
    [TBL] [Abstract][Full Text] [Related]  

  • 4. In vivo-in vitro correlations: predicting pulmonary drug deposition from pharmaceutical aerosols.
    Byron PR; Hindle M; Lange CF; Longest PW; McRobbie D; Oldham MJ; Olsson B; Thiel CG; Wachtel H; Finlay WH
    J Aerosol Med Pulm Drug Deliv; 2010 Dec; 23 Suppl 2():S59-69. PubMed ID: 21133801
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Validating CFD Predictions of Pharmaceutical Aerosol Deposition with In Vivo Data.
    Tian G; Hindle M; Lee S; Longest PW
    Pharm Res; 2015 Oct; 32(10):3170-87. PubMed ID: 25944585
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Model of the deposition of aerosol particles in the respiratory tract of the rat. II. Hygroscopic particle deposition.
    Ferron GA; Upadhyay S; Zimmermann R; Karg E
    J Aerosol Med Pulm Drug Deliv; 2013 Apr; 26(2):101-19. PubMed ID: 23550602
    [TBL] [Abstract][Full Text] [Related]  

  • 7. In vitro/in vivo comparisons in pulmonary drug delivery.
    Newman SP; Chan HK
    J Aerosol Med Pulm Drug Deliv; 2008 Mar; 21(1):77-84. PubMed ID: 18518834
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Artificial neural network prediction of the patterns of deposition of polydisperse aerosols within human lungs.
    Nazir J; Barlow DJ; Jayne Lawrence M; Shrubb I
    J Pharm Sci; 2005 Sep; 94(9):1986-97. PubMed ID: 16052546
    [TBL] [Abstract][Full Text] [Related]  

  • 9. In vitro tests for aerosol deposition. III: effect of inhaler insertion angle on aerosol deposition.
    Delvadia RR; Longest PW; Hindle M; Byron PR
    J Aerosol Med Pulm Drug Deliv; 2013 Jun; 26(3):145-56. PubMed ID: 23025452
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The Sophia Anatomical Infant Nose-Throat (Saint) model: a valuable tool to study aerosol deposition in infants.
    Janssens HM; de Jongste JC; Fokkens WJ; Robben SG; Wouters K; Tiddens HA
    J Aerosol Med; 2001; 14(4):433-41. PubMed ID: 11791684
    [TBL] [Abstract][Full Text] [Related]  

  • 11. CFD simulation of aerosol deposition in an anatomically based human large-medium airway model.
    Ma B; Lutchen KR
    Ann Biomed Eng; 2009 Feb; 37(2):271-85. PubMed ID: 19082892
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Surfactant Driven Post-Deposition Spreading of Aerosols on Complex Aqueous Subphases. 1: High Deposition Flux Representative of Aerosol Delivery to Large Airways.
    Khanal A; Sharma R; Corcoran TE; Garoff S; Przybycien TM; Tilton RD
    J Aerosol Med Pulm Drug Deliv; 2015 Oct; 28(5):382-93. PubMed ID: 25723759
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A case series on lung deposition analysis of inhaled medication using functional imaging based computational fluid dynamics in asthmatic patients: effect of upper airway morphology and comparison with in vivo data.
    Vinchurkar S; Backer LD; Vos W; Holsbeke CV; Backer JD; Backer WD
    Inhal Toxicol; 2012; 24(2):81-8. PubMed ID: 22260527
    [TBL] [Abstract][Full Text] [Related]  

  • 14. In vitro-in vivo correlations (IVIVCs) of deposition for drugs given by oral inhalation.
    Newman SP; Chan HK
    Adv Drug Deliv Rev; 2020 Dec; 167():135-147. PubMed ID: 32593641
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pulmonary targeting of nanoparticle drug matrices.
    Dandekar P; Venkataraman C; Mehra A
    J Aerosol Med Pulm Drug Deliv; 2010 Dec; 23(6):343-53. PubMed ID: 20455773
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The Development and Validation of an In Vitro Airway Model to Assess Realistic Airway Deposition and Drug Permeation Behavior of Orally Inhaled Products Across Synthetic Membranes.
    Huynh BK; Traini D; Farkas DR; Longest PW; Hindle M; Young PM
    J Aerosol Med Pulm Drug Deliv; 2018 Apr; 31(2):103-108. PubMed ID: 28880765
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Use of asthmatic pulmonary function test data to predict lung deposition.
    Robinson RJ; Doolittle RL; Diflorio JN
    J Aerosol Med; 2007; 20(2):141-62. PubMed ID: 17536952
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Inspiratory and expiratory aerosol deposition in the upper airway.
    Verbanck S; Kalsi HS; Biddiscombe MF; Agnihotri V; Belkassem B; Lacor C; Usmani OS
    Inhal Toxicol; 2011 Feb; 23(2):104-11. PubMed ID: 21309663
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Evaluation of the Respimat Soft Mist Inhaler using a concurrent CFD and in vitro approach.
    Worth Longest P; Hindle M
    J Aerosol Med Pulm Drug Deliv; 2009 Jun; 22(2):99-112. PubMed ID: 18956950
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Assessment methods of inhaled aerosols: technical aspects and applications.
    Jaafar-Maalej C; Andrieu V; Elaissari A; Fessi H
    Expert Opin Drug Deliv; 2009 Sep; 6(9):941-59. PubMed ID: 19637979
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.